Damn, but I love that word, “phytocannabinoid.” It’s true, I had to check the spelling ’cause it just doesn’t look right, but maybe that’s why I like it? It’s a weird word. Birds of a feather…
I’ve written before about the neuroprotectant (‘nother cool word) properties of the chemical compounds found in the plant. Still, when another study – by folks with all of those cool letters after their name – is released, I feel it gives further validity to the previous studies.
Some folks in the U.K. did one on the efficacy of cannabis extracts in the palliative treatment of MS. The abstract can be found in the Journal of Neurology, Neurosurgery and Psychiatry. unfortunately, to read the whole thing you best be ready to pony up some bones. But, for the meat of it:
Is 30% significant? I’m not sure. Oh, I’d guess that near a third would think so, but in the world of science… I dunno. Hell, the conclusion merely states that cannabis extracts are more effective than a placebo in relieving stiffness in MS patients.
Oh, but wait… Doesn’t GW Pharmaceuticals have an extract derived product on the market (in several countries) to treat MS ?
Sigh, move along here. There’s nothing to see – I guess. Hell, the U.S. Government has known of those properties since 2003 (earlier, actually).
Sorry for wasting your time.